Carlos Pérez Montilla

Real-World Evidence of Factors Affecting Cannabidiol Exposure in Children with Drug-Resistant Developmental and Epileptic Encephalopathies

R. Caraballo, P. Schaiquevich, F. García Bournissen, 2023, Pharmaceutics.

Major benznidazole metabolites in patients treated for Chagas disease: mass spectrometry-based identification, structural analysis and detoxification pathways.

J. Altcheh, D. Rocco, N. González, 2023, Toxicology letters.

Pharmacokinetics of cannabidiol in children with refractory epileptic encephalopathy

R. Caraballo, G. Reyes, Robinson Gutiérrez, 2020, Epilepsia.